Among 44,497 women attending gynaecological services in three regions in 2021 to 2023, 8.5% carried high-risk HPV, and HPV 16 or 18, the types the vaccine prevents, accounted for 41.1% of infections.
Published as "Epidemiology of high-risk HPV in Uzbekistan among 44,000 women - genotypes, risk profiles and screening needs in Uzbekistan". Women aged 20 and over attending gynaecological services in Tashkent, Andijan and Samarkand had liquid-based cytology and HPV DNA testing for 12 high-risk types.
HPV prevalence data from three Uzbek regions, supporting HPV-based screening and vaccination.
Shares Republican Specialized Scientific-Practical Medical Center of Maternal and Child Health (Uzbekistan), Cervical cancer.
Shares Republican Specialized Scientific-Practical Medical Center of Maternal and Child Health (Uzbekistan), Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/